THE SAFETY PROFILE OF DE-NOL

[1] BENSAUDE R, 1909, ARCH FR MAL APP DIG, V3, P13

[2] BUGE A, 1974, NOUV PRESSE MED, V3, P2315

[3] REVERSIBLE ENCEPHALOPATHY POSSIBLY ASSOCIATED WITH BISMUTH SUBGALLATE INGESTION [J]. BRITISH MEDICAL JOURNAL, 1974, 1 (5901) : 220 - 223

[4] EFFECTS OF TRIPOTASSIUM DICITRATO BISMUTHATE (TDB) TABLETS OR CIMETIDINE IN THE TREATMENT OF DUODENAL-ULCER [J]. GUT, 1983, 24 (12) : 1148 - 1151

[5] HILLEMAND P, 1977, SEM HOP PARIS, V53, P1663

[6] HILLEMAND P, 1935, B GEN THER, V186, P35

[7] LEE SP, 1981, RES COMMUN CHEM PATH, V34, P359

[8] MARTINBOUYER G, 1980, THERAPIE, V35, P307

[9] MORROW AW, 1973, MED J AUSTRALIA, V60, P912

[1] BENSAUDE R, 1909, ARCH FR MAL APP DIG, V3, P13

[2] BUGE A, 1974, NOUV PRESSE MED, V3, P2315

[3] REVERSIBLE ENCEPHALOPATHY POSSIBLY ASSOCIATED WITH BISMUTH SUBGALLATE INGESTION [J]. BRITISH MEDICAL JOURNAL, 1974, 1 (5901) : 220 - 223

[4] EFFECTS OF TRIPOTASSIUM DICITRATO BISMUTHATE (TDB) TABLETS OR CIMETIDINE IN THE TREATMENT OF DUODENAL-ULCER [J]. GUT, 1983, 24 (12) : 1148 - 1151

[5] HILLEMAND P, 1977, SEM HOP PARIS, V53, P1663

[6] HILLEMAND P, 1935, B GEN THER, V186, P35

[7] LEE SP, 1981, RES COMMUN CHEM PATH, V34, P359

[8] MARTINBOUYER G, 1980, THERAPIE, V35, P307

[9] MORROW AW, 1973, MED J AUSTRALIA, V60, P912